Add time:07/17/2019         Source:sciencedirect.com

A sensitive and selective high-performance liquid chromatographic (HPLC) method was developed for the determination of 1,3-di(4-imidazolino-2-methoxyphenoxy)propane (DMP) in rat, dog and human plasma (50–5000 ng/ml) and urine (0.1–10 μg/ml). DMP and DMPent (dimethoxyimidizolinopentamidine, the internal standard), are extracted from alkanized plasma with n-butyl chloride—n-butanol (9:1, v/v). The organic phase is dried under nitrogen, reconstituted in mobile phase, and washed with hexane. Separation is achieved by ion-pair chromatography on a Zorbax Rx C8 column with fluorescence detection. The analysis of pooled plasma (80, 400, and 4000 ng/ml) and urine controls (0.3, 1.6, and 8 μg/ml) demonstrated excellent precision and accuracy over a three-day period. The recovery of DMP is >90% from rat, dog, and human plasma and >85% from rat and human urine, and 60–70% from dog urine. The limit of quantitation (LOQ) of the assay is 50 ng/ml in rat, dog and human plasma. Using the high-sensitivity assay, the limit of quantitation was decreased to 5, 2 and 0.6 ng/ml in rat, dog and human plasma, respectively. The LOQ of the assay is 0.1 μg/ml in rat, dog and human urine. The assay was used to determine plasma and urine concentrations of DMP in pharmacokinetic studies in rat and dog.

We also recommend Trading Suppliers and Manufacturers of 1,3-Di-(4-imidazolino-2-methoxyphenoxy)propane (cas 109444-03-3). Pls Click Website Link as below: cas 109444-03-3 suppliers